127 related articles for article (PubMed ID: 10968287)
1. Stereo-enriched phosphorothioate oligodeoxynucleotides: synthesis, biophysical and biological properties.
Yu D; Kandimalla ER; Roskey A; Zhao Q; Chen L; Chen J; Agrawal S
Bioorg Med Chem; 2000 Jan; 8(1):275-84. PubMed ID: 10968287
[TBL] [Abstract][Full Text] [Related]
2. Accessible 5'-end of CpG-containing phosphorothioate oligodeoxynucleotides is essential for immunostimulatory activity.
Yu D; Zhao Q; Kandimalla ER; Agrawal S
Bioorg Med Chem Lett; 2000 Dec; 10(23):2585-8. PubMed ID: 11128629
[TBL] [Abstract][Full Text] [Related]
3. Stability of stereoregular oligo(nucleoside phosphorothioate)s in human plasma: diastereoselectivity of plasma 3'-exonuclease.
Koziołkiewicz M; Wójcik M; Kobylańska A; Karwowski B; Rebowska B; Guga P; Stec WJ
Antisense Nucleic Acid Drug Dev; 1997 Feb; 7(1):43-8. PubMed ID: 9055038
[TBL] [Abstract][Full Text] [Related]
4. P-chirality-dependent immune activation by phosphorothioate CpG oligodeoxynucleotides.
Krieg AM; Guga P; Stec W
Oligonucleotides; 2003; 13(6):491-9. PubMed ID: 15025915
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biophysical properties and biological activity of second generation antisense oligonucleotides containing chiral phosphorothioate linkages.
Wan WB; Migawa MT; Vasquez G; Murray HM; Nichols JG; Gaus H; Berdeja A; Lee S; Hart CE; Lima WF; Swayze EE; Seth PP
Nucleic Acids Res; 2014 Dec; 42(22):13456-68. PubMed ID: 25398895
[TBL] [Abstract][Full Text] [Related]
6. Pseudo-cyclic oligonucleotides: in vitro and in vivo properties.
Jiang Z; Kandimalla ER; Zhao Q; Shen LX; DeLuca A; Normano N; Ruskowski M; Agrawal S
Bioorg Med Chem; 1999 Dec; 7(12):2727-35. PubMed ID: 10658577
[TBL] [Abstract][Full Text] [Related]
7. Stereodefined phosphorothioate analogues of DNA: relative thermodynamic stability of the model PS-DNA/DNA and PS-DNA/RNA complexes.
Boczkowska M; Guga P; Stec WJ
Biochemistry; 2002 Oct; 41(41):12483-7. PubMed ID: 12369839
[TBL] [Abstract][Full Text] [Related]
8. Immunostimulatory activity of CpG containing phosphorothioate oligodeoxynucleotide is modulated by modification of a single deoxynucleoside.
Zhao Q; Yu D; Agrawal S
Bioorg Med Chem Lett; 2000 May; 10(10):1051-4. PubMed ID: 10843214
[TBL] [Abstract][Full Text] [Related]
9. Stereodifferentiation--the effect of P chirality of oligo(nucleoside phosphorothioates) on the activity of bacterial RNase H.
Koziolkiewicz M; Krakowiak A; Kwinkowski M; Boczkowska M; Stec WJ
Nucleic Acids Res; 1995 Dec; 23(24):5000-5. PubMed ID: 8559657
[TBL] [Abstract][Full Text] [Related]
10. Stereodependent inhibition of plasminogen activator inhibitor type 1 by phosphorothioate oligonucleotides: proof of sequence specificity in cell culture and in vivo rat experiments.
Stec WJ; Cierniewski CS; Okruszek A; Kobylańska A; Pawłowska Z; Koziołkiewicz M; Pluskota E; Maciaszek A; Rebowska B; Stasiak M
Antisense Nucleic Acid Drug Dev; 1997 Dec; 7(6):567-73. PubMed ID: 9450914
[TBL] [Abstract][Full Text] [Related]
11. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides.
Galderisi U; Di Bernardo G; Melone MA; Galano G; Cascino A; Giordano A; Cipollaro M
J Cell Biochem; 1999 Jul; 74(1):31-7. PubMed ID: 10381259
[TBL] [Abstract][Full Text] [Related]
12. Stereocontrolled solid-phase synthesis of phosphorothioate oligoribonucleotides using 2'-O-(2-cyanoethoxymethyl)-nucleoside 3'-O-oxazaphospholidine monomers.
Nukaga Y; Yamada K; Ogata T; Oka N; Wada T
J Org Chem; 2012 Sep; 77(18):7913-22. PubMed ID: 22931131
[TBL] [Abstract][Full Text] [Related]
13. Phosphorothioate-phosphodiester oligonucleotide co-polymers: assessment for antisense application.
Ghosh MK; Ghosh K; Cohen JS
Anticancer Drug Des; 1993 Feb; 8(1):15-32. PubMed ID: 8386513
[TBL] [Abstract][Full Text] [Related]
14. Patterns of intracellular compartmentalization, trafficking and acidification of 5'-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells.
Tonkinson JL; Stein CA
Nucleic Acids Res; 1994 Oct; 22(20):4268-75. PubMed ID: 7937155
[TBL] [Abstract][Full Text] [Related]
15. Solid support synthesis of all-Rp-oligo(ribonucleoside phosphorothioate)s.
Almer H; Stawinski J; Strömberg R
Nucleic Acids Res; 1996 Oct; 24(19):3811-20. PubMed ID: 8871563
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of d(GC) and d(CG) octamers containing alternating phosphorothioate linkages: effect of the phosphorothioate group on the B-Z transition.
Cosstick R; Eckstein F
Biochemistry; 1985 Jul; 24(14):3630-8. PubMed ID: 4041432
[TBL] [Abstract][Full Text] [Related]
17. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
Gao WY; Han FS; Storm C; Egan W; Cheng YC
Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
[TBL] [Abstract][Full Text] [Related]
18. Conformational properties of 2',5' linked Rp- and Sp-phosphorothioate oligoadenylates studied by circular dichroism and NMR.
Shimazu M; Kawai G; Okutsu T; Shiozuka K; Sawai H
Biopolymers; 2003; 72(1):48-58. PubMed ID: 12400091
[TBL] [Abstract][Full Text] [Related]
19. Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16.
Storey A; Oates D; Banks L; Crawford L; Crook T
Nucleic Acids Res; 1991 Aug; 19(15):4109-14. PubMed ID: 1651476
[TBL] [Abstract][Full Text] [Related]
20. Cellular pharmacology and protein binding of phosphoromonothioate and phosphorodithioate oligodeoxynucleotides: a comparative study.
Tonkinson JL; Guvakova M; Khaled Z; Lee J; Yakubov L; Marshall WS; Caruthers MH; Stein CA
Antisense Res Dev; 1994; 4(4):269-78. PubMed ID: 7537561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
